“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Saturday, August 30, 2025

Aptalis


Aptalis products

CANASA
Indication: Treatment of ulcerative colitis and proctitis
Form: Rectal suppository

CARAFATE
Indication: Treatment of duodenal ulcer (gastrointestinal mucosal protection)
Form: Oral suspension or tablet

DELURSAN
Indication: Maintenance therapy for ulcerative colitis
Form: Oral delayed-release tablet

LACTEOL
Indication: Diarrhea management
Form: Oral formulation

PANZYTRAT / ZENPEP (pancrelipase)
Indication: Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency (e.g., in cystic fibrosis)
Form: Enteric-coated capsules of varying strengths

PYLERA (bismuth subcitrate/metronidazole/tetracycline)
Indication: Helicobacter pylori eradication in combination with omeprazole
Form: Oral capsules (given as part of a 10‑day therapy pack)

RECTIV
Indication: Pain relief for chronic anal fissure
Form: Topical ointment (nitroglycerin 0.4%)

SALOFALK
Indication: Maintenance treatment for ulcerative colitis
Form: Oral formulation (tablet or granules)

ULTRESA
Indication: Ulcerative colitis (delayed-release therapy)
Form: Oral delayed-release tablet



on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)